U.S. Residential REITs Stock News

NYSE:NRG
NYSE:NRGElectric Utilities

NRG Energy (NRG) Margin Compression Tests Bullish Profitability Narratives After FY 2025 Results

NRG Energy (NRG) closed out FY 2025 with fourth quarter revenue of US$7.8b and basic EPS of US$0.26, alongside net income of US$50m. Trailing twelve month figures show revenue of US$30.7b, EPS of US$4.09 and net income of US$797m. The company has seen revenue move from US$28.1b to US$30.7b on a trailing basis across the periods provided, with trailing EPS shifting from US$5.14 to US$4.09 over the same window. This sets up a picture where modest top line progress sits against tighter...
NasdaqGS:ONC
NasdaqGS:ONCBiotechs

Is It Time To Reconsider BeOne Medicines (ONC) After Mixed Recent Share Returns?

If you are trying to figure out whether BeOne Medicines is attractively priced or already reflects its potential, you are in the right place. The stock closed at US$352.23, with a 7 day return of a 0.6% decline, a 30 day return of 4.8%, and longer term returns of 13.2% year to date, 26.5% over 1 year, 46.6% over 3 years and 21.8% over 5 years. These mixed short term and longer term returns often prompt investors to look more closely at what might be driving sentiment and expectations. In...
NYSE:RCUS
NYSE:RCUSBiotechs

Is Arcus Biosciences (RCUS) Pricing Reflect Its 1‑Year Surge And Mixed Valuation Signals

If you are wondering whether Arcus Biosciences is attractively priced today, this article walks through what the current share price could imply about the company’s underlying value. The stock last closed at US$20.27, with returns of 4.3% over 7 days, a 9.8% decline over 30 days, a 13.0% decline year to date, a 99.9% gain over 1 year, a 16.4% return over 3 years and a 41.3% decline over 5 years. Recent attention around Arcus Biosciences has largely focused on its pipeline and partnerships in...
NasdaqGS:TXRH
NasdaqGS:TXRHHospitality

Is It Too Late To Consider Texas Roadhouse (TXRH) After Recent Share Price Softness

Wondering if Texas Roadhouse at about US$181.78 a share still offers value, or if most of the opportunity is already priced in? This article walks through what the numbers are actually saying about the stock. The share price has eased with an estimated 2.7% decline over the last 7 days and a 2.3% decline over the last 30 days, while longer term returns sit at 6.1% year to date and 5.1% over 1 year, with very large gains of 87.6% over 3 years and 111.3% over 5 years. Recent coverage around...
NYSE:NOMD
NYSE:NOMDFood

Nomad Foods Boosts 2025 Cash Returns As 2026 Reset Targets Value Creation

Nomad Foods (NYSE:NOMD) has set a shareholder capital return plan for 2025 that lifts dividends and share repurchases by 38% year on year. The company is also preparing broad organizational and planning changes for 2026 aimed at performance and value creation. This combination of higher cash returns and a reset year ahead marks a clear shift in how Nomad Foods is approaching capital allocation and its business setup. For investors looking at the frozen foods group today, Nomad Foods trades...
NasdaqGS:FLEX
NasdaqGS:FLEXElectronic

Is It Time To Reassess Flex (FLEX) After Its Strong 1 Year Share Price Run?

If you are wondering whether Flex shares still offer value after a strong run, this article walks through what the current price might be implying about the company. Flex recently closed at US$65.67, with a 7 day return of a 0.2% decline, a 30 day return of 3.0%, a year to date return of 3.1% and a 1 year return of 65.2%, while the 3 year return is very large and the 5 year return is also very large. Recent news coverage has tended to focus on Flex as an established player in electronics...
NasdaqGS:INVA
NasdaqGS:INVAPharmaceuticals

Innoviva’s NUZOLVENCE Approval And Buyback Reframe Growth And Valuation Story

Innoviva (NasdaqGS:INVA) received FDA approval for NUZOLVENCE, a first in class treatment for uncomplicated urogenital gonorrhea. The company announced a US$125 million share repurchase program alongside the approval. These updates point to meaningful shifts in Innoviva's specialty therapeutics focus and capital allocation approach. For you as an investor, NUZOLVENCE adds a new approved therapy to Innoviva's portfolio, aligning with its push in specialty therapeutics. Gonorrhea treatment is...
NYSE:GAM
NYSE:GAMCapital Markets

How General American Investors’ 2025 Earnings Gap Between Revenue and Profit Could Reshape GAM’s Narrative

General American Investors Company, Inc. has reported its full-year 2025 results, posting revenue of US$24.31 million and net income of US$339.84 million for the year ended December 31, 2025. The contrast between relatively modest revenue and very large net income highlights how investment gains can significantly shape this closed-end fund’s financial profile. With this unusually wide gap between revenue and net income, we’ll explore what the latest earnings mean for General American...
NYSE:TDY
NYSE:TDYElectronic

What Teledyne Technologies (TDY)'s Lepton XDS Dual-Spectrum Camera Launch Means For Shareholders

In February 2026, Teledyne FLIR OEM launched the Lepton XDS, an ITAR-free, dual-thermal-and-visible camera module that embeds its MSX edge-enhancement technology and Prism ISP software into a compact, low-power package for embedded, mobile, and industrial OEM applications. By combining radiometric thermal sensing, real-time thermal-visible fusion, and an industry-first RJPEG output in a SWaP-optimized module, Teledyne is pushing advanced imaging intelligence into space- and power-constrained...
NasdaqGM:PSNY
NasdaqGM:PSNYAuto

Polestar (PSNY) Is Up 20.4% After Unveiling Four-Model Expansion And Major Retail Buildout Plans

Earlier this month, Polestar announced its largest model expansion to date, planning four new vehicles by 2028, while targeting low double-digit volume growth in 2026 and a 30% expansion of its retail network. The company also highlighted meaningful progress on sustainability and technology, including emissions cuts per vehicle and the climate-focused Polestar 0 program, supported by a recent US$700,000,000 funding raise. We’ll now examine how this expanded four-model rollout and retail...
NYSE:PNC
NYSE:PNCBanks

Does PNC’s FirstBank Deal and Data‑Driven Expansion Strategy Reshape The Bull Case For PNC (PNC)?

Recently, PNC Financial Services Group announced the retirement of long-time executive Richard Bynum and promoted Stacy Juchno to chief corporate responsibility officer while elevating Mike Abriatis to general auditor and executive committee member, alongside unveiling new data products, community investments, lending deals and acquisition plans including an agreement to acquire FirstBank in Colorado and Arizona. Together with its new PNC Monthly Consumer Health Check and expanded affordable...
NYSE:PRU
NYSE:PRUInsurance

Is Prudential Financial (PRU) Pricing Look Attractive After Recent Share Price Weakness

If you are wondering whether Prudential Financial at around US$100.86 is offering fair value or a potential bargain, you are in the right place. The share price has seen a 3.3% decline over the last 7 days and a 7.5% decline over the last 30 days. The 3 year and 5 year returns of 17.3% and 43.5% give longer term holders a different picture compared with the 11.4% year to date and 5.1% 1 year declines. Recent coverage of Prudential Financial has focused on how investors interpret these mixed...
NYSE:ACM
NYSE:ACMConstruction

Is TomTom Traffic Data Access Quietly Redefining AECOM’s Digital Infrastructure Ambitions (ACM)?

Earlier in February, TomTom announced a global partnership with AECOM, giving AECOM access to TomTom’s real-time and historic traffic data products to enhance mobility planning, transport modelling, and traffic management for public and private clients worldwide. Alongside this partnership, AECOM’s upcoming presentations at Citi’s Global Industrial Tech & Mobility Conference and Barclays’ Industrial Select Conference highlight how data-driven, technology-enabled solutions are becoming more...
NYSE:EPRT
NYSE:EPRTREITs

Does Essential Properties’ US$350 Million Equity Raise Change The Bull Case For EPRT?

In February 2026, Essential Properties Realty Trust, Inc. completed a follow-on equity offering of approximately US$350,000,000, issuing 10,869,565 common shares at US$32.20 each, a US$1.288 discount to the offer price. This sizable equity raise increases the company’s capital pool but also adds to share count, making dilution and capital deployment efficiency key issues for investors to watch. Next, we’ll examine how this completed US$350,000,000 equity raise could influence Essential...
NYSE:SKT
NYSE:SKTRetail REITs

Tanger (SKT) Interest Coverage Concerns Challenge Bullish Earnings Narratives

Tanger FY 2025 Earnings Snapshot Tanger (SKT) has wrapped up FY 2025 with fourth quarter revenue of US$160.3 million and basic EPS of US$0.29, while trailing twelve month revenue sits at US$581.6 million and EPS at US$1.01. The company has seen revenue move from US$537.4 million to US$581.6 million over the last year, with EPS shifting from US$0.89 to US$1.01 on a trailing basis, giving investors a clear view of how the top line and per share earnings have tracked together. With net margins...
NYSE:SN
NYSE:SNConsumer Durables

A Look At SharkNinja (SN) Valuation After The Shark SilkiPro Straight Product Debut

Why the Shark SilkiPro Straight launch matters for SharkNinja stock SharkNinja (SN) has introduced the Shark SilkiPro Straight, a free-standing air straightener that uses Intelligent Ceramic Heat, RapidDry Technology, and HeatSense Ceramic Plates to target safer, faster styling for a wide range of hair types. The product sits within Shark Beauty’s For All Hair Kind platform. It uses interchangeable combs and salon inspired techniques to offer wet to dry straightening and varied styles in a...
NYSE:HL
NYSE:HLMetals and Mining

Abitibiwinni Talks Add New Risk To Hecla Casa Berardi Sale

Abitibiwinni First Nation has called on Hecla Mining (NYSE:HL) and Orezone Gold to hold good faith talks about respecting Aboriginal rights in the proposed sale of Hecla Quebec and the Casa Berardi Mine. The First Nation is seeking meaningful engagement on how the transaction could affect its rights and interests linked to the mine and surrounding territory. The request introduces an additional consideration for the timing, terms, and conditions of the planned sale process. Hecla Mining,...
NasdaqGM:EXPI
NasdaqGM:EXPIReal Estate

eXp World Holdings FY 2025 Losses Keep Profitability Narrative Under Pressure

eXp World Holdings FY 2025 results set the stage for a profit-focused narrative eXp World Holdings (EXPI) has wrapped up FY 2025 with Q4 revenue of US$1.2b and a basic EPS loss of US$0.08, putting a clear spotlight on how efficiently the business is turning its top line into profits. The company has seen quarterly revenue range from US$954.9m in Q1 2025 to US$1.3b in Q3 2025, while EPS has swung between a loss of US$0.07 in Q1 2025 and a small profit of US$0.02 in Q3 2025. Investors will...
NYSE:LADR
NYSE:LADRMortgage REITs

Is Ladder Capital (LADR) Pricing Look Stretching After Recent Share Price Softness

If you are wondering whether Ladder Capital's current share price lines up with its underlying worth, you are not alone. This article is designed to help you frame that question clearly. The stock last closed at US$10.44, with returns of 0.3% over the past week, a 5.9% decline over the past month, a 5.9% decline year to date, and total returns of a 2.7% decline over 1 year, 21.1% over 3 years, and 34.0% over 5 years. Recent coverage has focused on Ladder Capital as a US listed commercial...
NYSE:ES
NYSE:ESElectric Utilities

A Look At Eversource Energy’s Valuation As Winter Storm Outages Put Grid Resilience In Focus

A severe winter storm in the northeastern U.S. has put Eversource Energy (ES) in focus, with more than 206,000 customers experiencing outages. This has brought weather-related operational risks and grid resilience into sharper relief for investors. See our latest analysis for Eversource Energy. Beyond the storm outages, Eversource Energy has had an eventful start to 2026, including updated full year earnings guidance and a US$750 million fixed income offering. With the share price at US$74.92...
NYSE:MTRN
NYSE:MTRNMetals and Mining

A Look At Materion (MTRN) Valuation After Earnings Turnaround And 2026 Growth Guidance

Materion (MTRN) is back on investors’ radar after reporting positive fourth quarter and full year 2025 earnings, reversing a prior year quarterly loss, along with fresh 2026 guidance that points to higher sales and improved margins. See our latest analysis for Materion. The upbeat 2025 results and fresh 2026 guidance arrive alongside strong recent momentum, with a 30 day share price return of 18.87% and a 1 year total shareholder return of 74.61% pointing to improving sentiment around...
NYSE:WLK
NYSE:WLKChemicals

Westlake (WLK) Posts US$1.5b Trailing Loss Testing Profit Recovery Narratives

Westlake (WLK) has wrapped up FY 2025 with fourth quarter revenue of US$2.5b and a basic EPS loss of US$4.24, alongside net income excluding extra items of a US$544m loss, setting a cautious tone around profitability. Over recent periods the company has seen quarterly revenue range from US$2.8b to US$3.0b while EPS shifted from a small profit of US$0.05 in Q4 2024 to a series of quarterly losses in 2025. That kind of earnings pressure keeps the focus squarely on margins and how quickly...
NYSE:BAH
NYSE:BAHProfessional Services

Booz Allen Slowdown Tests Civil Revenues While Valuation Signals Potential Upside

Booz Allen Hamilton Holding (NYSE:BAH) is reporting its largest business slowdown to date as federal cost-cutting leads to revenue declines. Management now expects conditions to stabilize but is cautioning investors about a pronounced downturn in civil sector revenues. The company is also dealing with fallout from a recently disclosed data breach that has contributed to government contract cancellations. These developments are unfolding alongside new global tariff measures that are affecting...
NYSE:OGN
NYSE:OGNPharmaceuticals

Organon Refocuses On Contraception With MIUDELLA Deal And JADA Exit

Organon (NYSE:OGN) has entered an exclusive global licensing agreement for MIUDELLA, a hormone-free copper IUD and the first such device approved in the U.S. in roughly 40 years. The company has also completed the sale of its JADA System to Laborie Medical, refining its focus within reproductive and postpartum health. For investors watching NYSE:OGN, these moves come as the stock trades around $7.51, with a 1-year return of a 51% decline and a 3-year return of a 64.5% decline. The recent...